Jason Weatherald MD
@AlbertaPHdoc
Followers
3K
Following
24K
Media
222
Statuses
4K
Associate Prof @UAlberta_DoM #YEG #Edmonton 🫁 🫀 Pulmonary Hypertension & Lung Transplant MD, Researcher in #PAH #CTEPH #PulmonaryEmbolism #COVID19 #Transplant
Edmonton, Alberta
Joined December 2020
nolite de bastardes carborundorum.
Hi kids . #HandmaidsTale (the book not the series!) has just been banned in #Edmonton…don’t read it, your hair will catch on fire! Get one now before they have public book burnings of it.
0
0
1
RT @DrStephenArcher: Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to….
academic.oup.com
AbstractBackground and Aims. Multiple germline gene variants promote familial and idiopathic pulmonary arterial hypertension (PAH); however, none are consi
0
16
0
RT @mark_toshner: 10k patients is an unusual achievement in rare diseases like pulmonary hypertension. Here we hit that milestone in work i….
pubmed.ncbi.nlm.nih.gov
We establish a relationship between CRP and BMI across all-cause PH, though CRP and BMI associate with diverging clinical outcomes. Inflammation and obesity are relevant phenotypes for consideration...
0
7
0
RT @ProfJDChalmers: We did it! The first approved medication for bronchiectasis.Brensocatib approved by the FDA in the United States. A gre….
0
90
0
RT @SandeepSahayMD: Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience h….
0
11
0
RT @BrunoRaphaelDd: RV response to exercise in PH: homeometric (↑contractility, preserved coupling) vs. heterometric (↓prognosis). ΔsPAP an….
0
15
0
Excited to finally share our @LindAlliance #Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽🔬. Supported by @CNTRP @AlbertaLung @AB_OTDT . A Canadian 🇨🇦 collaboration.@UAlberta_FoMD @UCalgaryMed @ubcmedvid .@UHNTransplant @med_umontreal .
jhltopen.org
This study employed the James Lind Alliance Priority Setting Partnership methodology to identify and prioritize research priorities in lung transplantation through engagement of pre- and post-lung...
0
3
5
RT @LukaszukAB: Now we need everyone’s help. Please, register here and help us collect petition signatures everywhere in Alberta. This is….
forever-canadian.ca
Forever Canadian campaign is a grassroots coalition of Canadians aimed at reinforcing Canadian unity. It is a proactive vehicle to secure Alberta's continued place in Canada.
0
452
0
RT @PVRI: 📢 Good news! 📢Our #PHGPS, the largest global survey exploring the perspectives of #PulmonaryHypertension patients, has identified….
0
6
0
RT @AssociationWsph: 📢WSPH Association is proud and happy to announce that the next World Symposium on Pulmonary Hypertension will be held….
0
12
0
RT @PfParks: EDM Zone avg LWBS is actually 16% for ALL of its EDs and objectively getting worse. Three of the ED's have LWBS numbers over 2….
0
32
0
RT @drslmd: Edmonton is also a major transplant centre that not only serves AB, but Saskatchewan and Manitoba.
0
19
0
RT @JMeddings: The cycle of private healthcare. It is now one of the biggest industries in the US. The outlier, first world country with th….
0
48
0
RT @JMeddings: John I agree with you but also have some definite beliefs of my own here. I'm going to put them out in a short thread. Man….
0
17
0
RT @Michael_Harhay: Trial Analysis & Interpretation in Critical Care Using the Evidential (Likelihood) Approach. OA @ATSBlueEditor: .https….
0
6
0
RT @ProfJDChalmers: Please take part in our survey and help us to find better ways to treat bronchiectasis and support patients .#worldbron….
0
8
0
RT @rjbernardoMD: Waiting for the publication @AlbertaPHdoc @SandeepSahayMD @Viniciodjperez @RyanTedfordMD .
merck.com
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy HYPERION, third Phase 3 study to...
0
2
0
RT @MaryCushmanMD: Is this the end of rivaroxaban for acute VTE?.@LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban….
0
125
0
RT @ProfJDChalmers: The new European Respiratory Journal impact factor is 21. Ranked #2 across all resp journals. Thank you to the incredib….
0
21
0
RT @UAlberta_DoM: Congratulations to the Department of Medicine Class of '25 who are graduating today! Read more about seven of our graduat….
0
4
0